日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice

编码分泌型非稳定刺突蛋白的 SARS-CoV-2 mRNA 疫苗在雌性小鼠中的免疫原性和保护效果

Eakachai Prompetchara, Chutitorn Ketloy, Mohamad-Gabriel Alameh, Kittipan Tharakhet, Papatsara Kaewpang, Nongnaphat Yostrerat, Patrawadee Pitakpolrat, Supranee Buranapraditkun, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Anan Jongkaewwattana, Taweewan Hunsawong, Rawiwan Im-Erbsin, Matthew Reed

CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2

CHO 生产的 RBD-Fc 亚单位疫苗与替代佐剂一起产生针对 SARS-CoV-2 的免疫反应

Sedthawut Laotee, Methawee Duangkaew, Araya Jivapetthai, Kittipan Tharakhet, Papatsara Kaewpang, Eakachai Prompetchara, Supaporn Phumiamorn, Sompong Sapsutthipas, Sakalin Trisiriwanich, Thitiporn Somsaard, Sittiruk Roytrakul, Parichat Duangkhae, Boonsri Ongpipattanakul, Patanachai Limpikirati, Natap

Translating a Thin-Film Rehydration Method to Microfluidics for the Preparation of a SARS-CoV-2 DNA Vaccine: When Manufacturing Method Matters

将薄膜补液法转化为微流体技术以制备 SARS-CoV-2 DNA 疫苗:制造方法至关重要

Allegra Peletta, Eakachai Prompetchara, Kittipan Tharakhet, Papatsara Kaewpang, Supranee Buranapraditkun, Nongnaphat Yostrerat, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Jonathan Avaro, Leonard Krupnik, Antonia Neels, Kiat Ruxrungtham, Chutitorn Ketloy, Gerrit Borchard

Feasibility of plant-expression system for production of recombinant anti-human IgE: An alternative production platform for therapeutic monoclonal antibodies

植物表达系统生产重组抗人IgE的可行性:一种用于治疗性单克隆抗体的替代生产平台

Hanittinan, Oranicha; Rattanapisit, Kaewta; Malla, Ashwini; Tharakhet, Kittipan; Ketloy, Chutitorn; Prompetchara, Eakachai; Phoolcharoen, Waranyoo

Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates

植物生产的SARS-CoV-2受体结合域在小鼠和非人灵长类动物中引发强效中和反应

Siriwattananon, Konlavat; Manopwisedjaroen, Suwimon; Shanmugaraj, Balamurugan; Rattanapisit, Kaewta; Phumiamorn, Supaporn; Sapsutthipas, Sompong; Trisiriwanich, Sakalin; Prompetchara, Eakachai; Ketloy, Chutitorn; Buranapraditkun, Supranee; Wijagkanalan, Wassana; Tharakhet, Kittipan; Kaewpang, Papatsara; Leetanasaksakul, Kantinan; Kemthong, Taratorn; Suttisan, Nutchanat; Malaivijitnond, Suchinda; Ruxrungtham, Kiat; Thitithanyanont, Arunee; Phoolcharoen, Waranyoo

DNA Vaccine Administered by Cationic Lipoplexes or by In Vivo Electroporation Induces Comparable Antibody Responses against SARS-CoV-2 in Mice.

通过阳离子脂质体复合物或体内电穿孔给药的DNA疫苗在小鼠体内诱导了针对SARS-CoV-2的类似抗体反应

Peletta Allegra, Prompetchara Eakachai, Tharakhet Kittipan, Kaewpang Papatsara, Buranapraditkun Supranee, Techawiwattanaboon Teerasit, Jbilou Tayeb, Krangvichian Pratomporn, Sirivichayakul Sunee, Manopwisedjaroen Suwimon, Thitithanyanont Arunee, Patarakul Kanitha, Ruxrungtham Kiat, Ketloy Chutitorn, Borchard Gerrit

DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice

编码SARS-CoV-2刺突蛋白的DNA疫苗候选物在小鼠体内诱导了强效的体液免疫和Th1细胞介导的免疫反应。

Prompetchara, Eakachai; Ketloy, Chutitorn; Tharakhet, Kittipan; Kaewpang, Papatsara; Buranapraditkun, Supranee; Techawiwattanaboon, Teerasit; Sathean-Anan-Kun, Suwitra; Pitakpolrat, Patrawadee; Watcharaplueksadee, Supaporn; Phumiamorn, Supaporn; Wijagkanalan, Wassana; Patarakul, Kanitha; Palaga, Tanapat; Ruxrungtham, Kiat